Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC
Condition: Non Small Cell Lung Cancer · Sponsor: Nuvation Bio Inc.
About this study
The main purpose of the study is to evaluate safety and efficacy of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of advanced NSCLC.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (77)
| Beverly Hills Cancer Center | Beverly Hills, California, United States | — |
| The Oncology Institute of Hope and Innovation | Glendale, California, United States | — |
| Moores Cancer Center at UC San Diego | La Jolla, California, United States | — |
| Keck Medicine of University of Southern California | Los Angeles, California, United States | — |
| UCI Medical Center | Orange, California, United States | — |
| Ventura County Hematology-Oncology Specialists | Oxnard, California, United States | — |
| SCRI - Florida Cancer Specialists South | Fort Meyers, Florida, United States | — |
| Memorial Cancer Institute at Memorial Hospital East | Hollywood, Florida, United States | — |
| Cancer Specialists of North Florida | Jacksonville, Florida, United States | — |
| Memorial Cancer Institute at Memorial Hospital West | Pembroke Pines, Florida, United States | — |
| SCRI - Hematology Oncology Clinic | Baton Rouge, Louisiana, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
+ 65 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04919811